101![Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research From: Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research From:](https://www.pdfsearch.io/img/4dda6a5a3155afb5d7e5750e4d857d9a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
102![(System Info[removed]SMITH MICHAEL[removed]:44:31 SMITHM) RECORD OF TELEPHONE CONVERSATION Submission Type: BLA Submission ID: [removed] (System Info[removed]SMITH MICHAEL[removed]:44:31 SMITHM) RECORD OF TELEPHONE CONVERSATION Submission Type: BLA Submission ID: [removed]](https://www.pdfsearch.io/img/18783b16b7b5ab9d2b4bc504f9235ca0.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
103![DEPARTMENT OF HEALTH & HUMAN SERVICES FDA, Center for Biologics Evaluation and Research MEMORANDUM Date: 27 October 2014 DEPARTMENT OF HEALTH & HUMAN SERVICES FDA, Center for Biologics Evaluation and Research MEMORANDUM Date: 27 October 2014](https://www.pdfsearch.io/img/694277fc9d1e39a709672c1489226b83.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
104![Providing Regulatory Submissions in Electronic Format — Submissions Under Section 745A(a) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry Providing Regulatory Submissions in Electronic Format — Submissions Under Section 745A(a) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry](https://www.pdfsearch.io/img/852fb398ce5825065c6fe8c7c71b7b9b.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
105![Memorandum Food and Drug Administration Center for Biologics Evaluation and Research Office of Compliance and Biologics Quality Division of Manufacturing and Product Quality To: Memorandum Food and Drug Administration Center for Biologics Evaluation and Research Office of Compliance and Biologics Quality Division of Manufacturing and Product Quality To:](https://www.pdfsearch.io/img/78d4825f85c2278885e947c91284e4d7.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
106![RECORD OF TELEPHONE CONVERSATION Submission Type: BLA Submission ID: [removed]Office: OVRR RECORD OF TELEPHONE CONVERSATION Submission Type: BLA Submission ID: [removed]Office: OVRR](https://www.pdfsearch.io/img/e02c620fee18731a3f352fb34eb6dd57.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
107![PDUFA V Annual IT Assessment FY2014 PDUFA V Annual IT Assessment FY2014](https://www.pdfsearch.io/img/3a439c74323ef5af9c88fb364d0838b2.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
108![[removed]Federal Register / Vol. 63, No[removed]Thursday, May 14, [removed]Proposed Rules failure of the hydraulic extension system, accomplish the following: [removed]Federal Register / Vol. 63, No[removed]Thursday, May 14, [removed]Proposed Rules failure of the hydraulic extension system, accomplish the following:](https://www.pdfsearch.io/img/b4f6a114807fb55647d1634473f1b1ed.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
109![Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products: Draft Guidance for Industry and Food and Drug Administration Staff Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products: Draft Guidance for Industry and Food and Drug Administration Staff](https://www.pdfsearch.io/img/e0b24b9d8e9cb0f3b804b572df4dfab4.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
110![Summary Basis for Regulatory Action Date: October 29, 2014 From: Drusilla L Burns, Ph.D., Chair of the Review Committee BLA/ STN#: [removed]Applicant Name: Wyeth Pharmaceuticals Inc. Date of Submission: June 16, 2014 Summary Basis for Regulatory Action Date: October 29, 2014 From: Drusilla L Burns, Ph.D., Chair of the Review Committee BLA/ STN#: [removed]Applicant Name: Wyeth Pharmaceuticals Inc. Date of Submission: June 16, 2014](https://www.pdfsearch.io/img/5191ad41900548d41b7f8a3e7faffbd2.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|